The investment seeks to provide long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PARWX | 57.32 | 0.30 | +0.53% |
Parnassus Value Equity Investor | |||
GILLX | 23.90 | 0.10 | +0.42% |
Goldman Sachs Enhanced U.S. Equity Inst | |||
VECRX | 22.33 | 0.07 | +0.31% |
Virtus KAR Equity Income R6 | |||
FBTIX | 30.97 | N/A | N/A |
Fidelity Advisor Biotechnology I | |||
NZDCHF | 0.48 | N/A | N/A |
New Zealand Dollar - Switzerland Franc |
A.I.dvisor indicates that over the last year, DHLAX has been closely correlated with VIVAX. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHLAX jumps, then VIVAX could also see price increases.
Ticker / NAME | Correlation To DHLAX | 1D Price Change % | ||
---|---|---|---|---|
DHLAX | 100% | +0.47% | ||
VIVAX - DHLAX | 86% Closely correlated | +0.41% | ||
VVIAX - DHLAX | 86% Closely correlated | +0.41% | ||
VIVIX - DHLAX | 86% Closely correlated | +0.41% | ||
DOXGX - DHLAX | 82% Closely correlated | +0.26% | ||
DODGX - DHLAX | 82% Closely correlated | +0.25% | ||
More |